Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Societal CDMO, Inc. (SCTL)

1.82   0.01 (0.55%) 11-28 10:05
Open: 1.83 Pre. Close: 1.81
High: 1.85 Low: 1.8
Volume: 10,442 Market Cap: 103(M)

Technical analysis

as of: 2022-11-28 9:52:03 AM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 2.16     One year: 2.52
Support: Support1: 1.59    Support2: 1.42
Resistance: Resistance1: 1.85    Resistance2: 2.16
Pivot: 1.69
Moving Average: MA(5): 1.78     MA(20): 1.68
MA(100): 1.37     MA(250): 1.39
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 88     %D(3): 82.7
RSI: RSI(14): 63.8
52-week: High: 2.19  Low: 0.62
Average Vol(K): 3-Month: 57 (K)  10-Days: 47 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ SCTL ] has closed below upper band by 15.7%. Bollinger Bands are 22.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.81 - 1.82 1.82 - 1.83
Low: 1.65 - 1.66 1.66 - 1.67
Close: 1.79 - 1.81 1.81 - 1.82

Company Description

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Headline News

Mon, 14 Nov 2022
Cingulate Inc. Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update - Marketscreener.com

Thu, 10 Nov 2022
Societal CDMO: Q3 Earnings Snapshot - Tri-City Herald

Wed, 09 Nov 2022
Societal CDMO, Inc. Reports In-Line Q3 EPS By Investing.com - Investing.com India

Wed, 09 Nov 2022
Societal CDMO, Inc. (SCTL) CEO Q3 2022 Earnings Call Transcript - Seeking Alpha

Tue, 08 Nov 2022
Notable earnings after Wednesday's close - Seeking Alpha

Tue, 08 Nov 2022
A Preview Of Societal CDMO's Earnings - Societal CDMO (NASDAQ:SCTL) - Benzinga

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 57 (M)
Shares Float 41 (M)
% Held by Insiders 11.6 (%)
% Held by Institutions 53.8 (%)
Shares Short 430 (K)
Shares Short P.Month 460 (K)

Stock Financials

EPS -0.26
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.62
Profit Margin (%) -14.9
Operating Margin (%) 2.2
Return on Assets (ttm) 0.8
Return on Equity (ttm) -32.8
Qtrly Rev. Growth 18.3
Gross Profit (p.s.) 0.34
Sales Per Share 1.55
EBITDA (p.s.) 0.17
Qtrly Earnings Growth 0
Operating Cash Flow -1 (M)
Levered Free Cash Flow -7 (M)

Stock Valuations

PE Ratio -7.08
PEG Ratio -0.6
Price to Book value 2.96
Price to Sales 1.18
Price to Cash Flow -86.95

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.